Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice

Amanda N. Sacino,Mieu Brooks,Michael A. Thomas,Alex B. McKinney,Sooyeon Lee,Robert W. Regenhardt,Nicholas H. McGarvey,Jacob I. Ayers,Lucia Notterpek,David R. Borchelt,Todd E. Golde,Benoit I. Giasson
DOI: https://doi.org/10.1073/pnas.1321785111
IF: 11.1
2014-07-07
Proceedings of the National Academy of Sciences
Abstract:Significance α-Synuclein (αS) inclusions are a hallmark of many progressive neurodegenerative disorders. Previously, intracerebral injection of exogenous preformed fibrillar αS in mouse models was shown to induce neuronal αS aggregation—a finding that has been interpreted as a prion-like mechanism. We now show that αS inclusion pathology can be induced in the brain and spinal cord of αS transgenic mice by a single peripheral intramuscular injection of αS. The formation of αS inclusions occurred concurrently with the presentation of a motor impairment in mice expressing mutant Ala53Thr human αS. This new model of robust and predictable induction of αS pathology will be especially valuable to further study the pathogenic mechanisms and assessment of therapeutic interventions.
What problem does this paper attempt to address?